STING1 and cancer: Our current finding that eribulin rapidly and specifically activates cGAS-STING through mtDNA release in both TNBC and immune cells including those that are terminally differentiated is significant particularly in solid tumors that have a much lower mitotic index than cancer cells in culture (Komlodi-Pasztor et al., 2011).